Arcadia BiosciencesRKDA
13F holders, Q4 2025 (December 31)13holders −3
0new positions
3sold out
$1.98avg. 13F price*
At the end of Q4 2025, 13 institutions reported holding Arcadia Biosciences Inc. (RKDA) in their 13F filings, down 3 from Q3 2025. 0 opened new positions and 3 sold out. The largest holders were Vanguard Group Inc. ($28K), State Street Corp. ($24K) and Geode Capital Management, LLC ($21K).
- Company
- Arcadia Biosciences Inc.
- CUSIP
- 039014303
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 3 | $77K |
All 13F filers, Q3 2025 → Q4 2025: 26,355 shares sold, net −26,355 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 13 holders
| Vanguard Group Inc. | 0.00% | No change | 14,038 | $28K |
| State Street Corp. | 0.00% | No change | 12,146 | $24K |
| Geode Capital Management, LLC | 0.00% | Reduce -18.0% | 10,655 | $21K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -12.5% | 1,476 | $3K |
| UBS Group AG | 0.00% | Reduce -48.6% | 565 | $1K |
| SBI Securities Co., Ltd. | 0.00% | Reduce -1.6% | 120 | $238 |
| Osaic Holdings, Inc. | 0.00% | No change | 75 | $148 |
| Group One Trading LLC | 0.00% | No change | 18 | $36 |
| Bank of America Corp. | 0.00% | No change | 12 | $24 |
| Assetmark, Inc. | 0.00% | No change | 5 | $10 |
| Morgan Stanley | 0.00% | Reduce -99.7% | 2 | $4 |
| Harbour Investments, Inc. | 0.00% | No change | 1 | $2 |
| Citigroup Inc. | 0.00% | Reduce -99.7% | 1 | $2 |
"% of holder's portfolio" is RKDA's weight in each manager's 13F, not the share of Arcadia Biosciences Inc. the manager owns.